Schizophrenia Archives

Live Event – Proposed Role Of Modulating Norepinephrine In Psychiatric Illnesses

Live Event November 12, 2025 6:30 pm to 8:30 pm CST

This live program examines the relationship between norepinephrine and psychiatric illnesses by investigating an overlap between monoaminergic pathways and circuitry, and demonstrating how malfunctioning cortical circuits can influence emotions, arousal,… Read More

Live Event – Proposed Role Of Modulating Norepinephrine In Psychiatric Illnesses

Live Event September 18, 2025 6:30 pm to 8:30 pm EDT

Live Event – Proposed Role Of Modulating Norepinephrine In Psychiatric Illnesses

Live Event September 30, 2025 7:00 pm to 9:00 pm EDT

Antipsychotic Treatment Options In Schizophrenia

Live Event June 20 6:00 pm to 7:30 pm EDT

In this presentation, the objectives are to: Review evolution of antipsychotic treatments. Discuss definitions of adherence and possible reasons for nonadherence. Compare evidence supporting oral and long-acting injectable antipsychotics. Discuss… Read More

Live Event – Trace Amine-Associated Receptor 1 (TAAR1): A Potential New Target For The Treatment of Schizophrenia

Live Event March 22 7:00 pm to 9:00 pm PDT

Speaker Elika Hefazi, PharmD, BCPP is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization… Read More

Live Event – Trace Amine-Associated Receptor 1 (TAAR1): A Potential New Target For The Treatment Of Schizophrenia

Live Event March 30 6:00 pm to 8:00 pm CDT

Speaker Steven Stoner, PharmD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Speakers Maria Perez, PharmD, AAHIVP and Clayton Levret, PharmD are employees of Otsuka Pharmaceutical Development… Read More

Live Event – Proposed Roles Of Modulating Norepinephrine In Psychiatric Illnesses

Live Event February 16 6:00 pm to 8:30 pm EST

Speaker Elizabeth DiNapoli, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc.,… Read More

Live Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Live Event November 14 6:00 pm to 8:30 pm EST

Live Event – Metabolic Wellness Consideration In Schizophrenia

Live Event September 1 12:00 pm to 1:00 pm PDT

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community;… Read More

Virtual Event – Distinguishing Sedation From Efficacy In Antipsychotic Treatment

Regional/Local August 18 9:30 pm to 10:30 pm EDT

Speakers John Awad, MD, BPharm and Michael Aldape, PhD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. Read More

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Stay Connected: